New early breast cancer drug to reduce risk of recurrence or death approved for Australian women

18 March 2019 - Nerlynx (neratinib) now approved by the Therapeutic Goods Administration for Australian women. ...

Read more →

Brexit - implications for therapeutic goods in Australia

18 March 2019 - In the event of a 'no deal' exit of the United Kingdom from the European Union, ...

Read more →

Vertex receives approval for Symdeko (tezacaftor/ivacaftor and ivacaftor) in Australia, to treat the underlying cause of cystic fibrosis in people aged 12 and older with certain CFTR gene mutations

12 March 2019 - A new treatment option for patients with two copies of the F508del mutation, the most common mutation ...

Read more →

Cluster randomised trials

4 March 2019 - Cluster randomised trials randomise groups of individuals rather than individuals themselves to interventions.  ...

Read more →

Whether the TGA should publish that a prescription medicine is under evaluation

15 February 2019 - The TGA is seeking comments from interested parties on whether or not the TGA should in future ...

Read more →

New weight loss pill launched in Australia

14 February 2019 - A new medication to help fight obesity has been launched in Australia. ...

Read more →

Sweet smell of success for patients taking the sugar pill

15 January 2019 - A placebo is anything that seems to offer a real medical treatment, but doesn’t. It could ...

Read more →

New drug to halve heart patients' cholesterol levels

9 January 2019 - A second drug has been approved for use in Australia for patients with high cholesterol who ...

Read more →

Revolutionary' cancer drug using genetically modified cells approved

19 December 2018 - A revolutionary cancer therapy that supercharges a patient's immune cells to hunt and destroy cancer cells ...

Read more →

PharmaMar announces the approval of Aplidin in Australia for the treatment of multiple myeloma

11 December 2018 - PharmaMar has licensed Aplidin to its partner, STA, in Australia, New Zealand and several Southeast Asian countries. ...

Read more →

CSL's improved flu vaccine won't reach Australia until 2021

5 December 2018 - Australians may have to wait until 2021 for CSL's new cell-based quadrivalent influenza vaccine, which was ...

Read more →

Australia's first telehealth cancer drug trial

3 December 2018 - A partnership between north Queensland hospitals is bringing potentially life-saving cancer drug trials to rural patients. ...

Read more →

Zambon announces approval and ARTG listing of safinamide in Australia for treatment of patients with Parkinson’s disease

30 November 2018 - Further regulatory submissions on-going with authorities worldwide. ...

Read more →

The Implant Files: How the Therapeutic Goods Administration regulates medical devices

27 November 2018 - There is good reason why the building that houses Australia's powerful regulator of drugs and medical ...

Read more →

Database tracks faulty medical devices across the globe

26 November 2018 - Patients across the world now have access to facts about faulty or dangerous medical devices — ...

Read more →